Trinseo (NYSE: TSE), the global materials solution provider and manufacturer of plastics, latex binders and synthetic rubber, announced today that its Consumer Essential Markets (CEM) business unit will now support medical device and pharmaceutical manufacturers of Drug Delivery Devices with specialty engineered polymer solutions.
Typical drug delivery devices, also known as combination devices that can use Trinseo materials include auto injectors, insulin pens, asthma inhalers, prefilled syringes and wearable devices. The Company’s specialty compounded solutions are ideal for a wide range of applications – acrylonitrile butadiene styrene (ABS) for housings, polycarbonate (PC) for windows and needle shield caps, and polystyrene (PS) for secondary packaging.
Trinseo materials are offered under the brands CALIBRE™ Polycarbonate Resins, CALIBRE™ MEGARAD™ Polycarbonate Resins, EMERGE™ Advanced Resins, STYRON™ Polystyrene Resins and MAGNUM™ ABS Resins. They provide advantages which are critical to the market such as:
Trinseo materials have been developed to meet the needs of manufacturers and molders - and they can be customized to meet exacting specifications. Trinseo medical grades have been biocompatibility tested and certain products are listed on a U.S. FDA Master Access File or Drug Master File.
The Company’s focus on drug delivery devices expands its support in the Medical Devices space which has included Single- and Multiple-Use Devices and Equipment Housings. As healthcare professionals embrace self-administered care they need devices that not only are effective therapeutically but also offer their patients functionality, convenience, haptics and aesthetics. Polymers are a big part of the challenge and Trinseo, with a foundation in medical polymers, intends to offer the solution.
Trinseo (NYSE: TSE), a specialty material solutions provider, partners with companies to bring ideas to life in an imaginative, smart, and sustainability-focused manner by combining its premier expertise, forward-looking innovations and best-in-class materials to unlock value for companies and consumers.
From design to manufacturing, Trinseo taps into decades of experience in diverse material solutions to address customers’ unique challenges in a wide range of industries, including consumer goods, mobility, building and construction, and medical.
Trinseo’s approximately 3,400 employees bring endless creativity to reimagining the possibilities with clients all over the world from the company’s locations in North America, Europe, and Asia Pacific. Trinseo reported net sales of approximately $4.8 billion in 2021. Discover more by visiting www.trinseo.com and connecting with Trinseo on LinkedIn, Twitter, Facebook and WeChat.
Cautionary Note on Forward-Looking Statements
This press release may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like "expect," "anticipate," "intend," "forecast," "outlook," "will," "may," "might," "see," "tend," "assume," "potential," "likely," "target," "plan," "contemplate," "seek," "attempt," "should," "could," "would" or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause future results to differ from those expressed by the forward-looking statements include, but are not limited to, our ability to successfully execute our transformation strategy and business strategy; our ability to integrate acquired businesses; global supply chain volatility, increased costs or disruption in the supply of raw materials or increased costs for transportation of our products; the nature of investment opportunities presented to the Company from time to time; and those factors discussed in our Annual Report on Form 10-K, under Part I, Item 1A —"Risk Factors" and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.